Market Indices
Latest News
 |
Mike Grondahl from Northland Securities issued a price target of $170.00...
June 25, 2026 SEZL 3.55% |
| ||
| ||
| ||
|
Price Targets
Mike Grondahl from Northland Securities issued a price target of $170.00 for SEZL on 2026-06-25 13:20:54.The adjusted price target was set to $170.00.At the time of the announcement,
June 25, 2026 SEZL 3.55%
from UBS issued a price target of $3.10 for INVE on 2026-06-25 13:18:53.The adjusted price target was set to $3.10.At the time of the announcement, INVE was...
June 25, 2026 INVE -29.54%
from D.A. Davidson issued a price target of $73.00 for CTRN on 2026-06-25 13:08:20.The adjusted price target was set to $73.00.At the time of the announcement, CTRN...
June 25, 2026 CTRN -11.45%
from Lake Street issued a price target of $4.00 for INVE on 2026-06-25 11:48:11.The adjusted price target was set to $4.00.At the time of the announcement, INVE...
June 25, 2026 INVE -29.54%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| SCLXW SCLXW | 0.19
37.87% | ||||||||||||||||||
| BZFDW BuzzFeed | 0.02
34.81% | ||||||||||||||||||
| LICN Lichen International Limi | 1.52
20.63% | ||||||||||||||||||
| DRTSW Alpha Tau Medical Ltd. Wa | 2.21
20.12% | ||||||||||||||||||
| ARBEW Arbe Robotics Ltd. Warran | 0.03
19.59% | ||||||||||||||||||
| ORMP Oramed Pharmaceuticals In | 4.99
16.02% | ||||||||||||||||||
| BNED Barnes & Noble Education, | 12.73
13.87% | ||||||||||||||||||
| ATAI Atai Beckley Inc. | 4.72
13.24% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 6.27%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 0.00%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 1.52%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.02%